A detailed history of Sei Investments CO transactions in Geron Corp stock. As of the latest transaction made, Sei Investments CO holds 177,587 shares of GERN stock, worth $594,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177,587
Previous 153,678 15.56%
Holding current value
$594,916
Previous $651,000 23.81%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.17 - $4.99 $99,700 - $119,305
23,909 Added 15.56%
177,587 $806,000
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $169,287 - $277,959
54,609 Added 55.12%
153,678 $651,000
Q1 2024

May 07, 2024

SELL
$1.75 - $3.44 $5,785 - $11,372
-3,306 Reduced 3.23%
99,069 $326,000
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $14,033 - $18,630
8,065 Added 8.55%
102,375 $216,000
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $48,857 - $75,948
23,155 Added 32.54%
94,310 $199,000
Q2 2023

Aug 11, 2023

BUY
$1.97 - $3.69 $7,891 - $14,782
4,006 Added 5.97%
71,155 $228,000
Q1 2023

May 12, 2023

BUY
$2.14 - $3.4 $143,698 - $228,306
67,149 New
67,149 $145,000
Q4 2017

Feb 08, 2018

SELL
$1.8 - $2.32 $36 - $46
-20 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$1.99 - $2.65 $39 - $53
20
20 $0

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.27B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.